Exercise capacity is the most powerful predictor of 2-year mortality in patients with left ventricular systolic dysfunction

Herz

Volumn 35, Issue 2, 2010, Pages 104-110

  Reibis, Rona K ^a,b   Treszl, Andras ^c   Wegscheider, Karl ^c   Ehrlich, Bettina ^a   Dissmann, Rüdiger ^d   Völler, Heinz ^a  

^a Klinik am See   (Germany)

^b Kardiologische Gemeinschaftspraxis   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Zentralkrankenhaus Reinkenheide   (Germany)

Author keywords

6 min walk test; Cardiovascular mortality; Exercise capacity; Left ventricular systolic dysfunction; Rehospitalization rate

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; PATIENT REFERRAL; PROGNOSIS; SYSTOLIC DYSFUNCTION;

AGED; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MULTIVARIATE ANALYSIS; MYOCARDIAL REVASCULARIZATION; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77952724322     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-010-3226-5     Document Type: Article

References (44)

1. R. Kerzner B.F. Gage K.E. Freedland, et al. 2003 Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction Am Heart J 146 286 290 10.1016/S0002-8703(03) 00151-0 12891197 (Pubitemid 36951773)
2. B. Pitt W. Remme F. Zannad, et al. 2003 Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 1309 1321 10.1056/NEJMoa030207 1:CAS:528:DC%2BD3sXis1ehurY%3D 12668699 (Pubitemid 36384098)
3. J.B. Young M.E. Dunlap M.A. Pfeffer, et al. 2004 Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials Circulation 110 2618 2626 10.1161/01.CIR.0000146819. 43235.A9 1:CAS:528:DC%2BD2cXos1Ght74%3D 15492298 (Pubitemid 39456438)
4. D.P. Zipes A.J. Camm M. Borggrefe, et al. 2006 ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines Writing (Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J Am Coll Cardiol 48 247 346 10.1016/j.jacc.2006.07.010 (Pubitemid 44382683)
5. S. Stewart K. MacIntyre D.J. Hole, et al. 2001 More "malignant" than cancer? Five-year survival following a first admission for heart failure Eur J Heart Fail 3 315 322 10.1016/S1388-9842(00)00141-0 1:STN:280: DC%2BD3M3psleruw%3D%3D 11378002 (Pubitemid 32895839)
6. I. Cygankiewicz W. Zareba R. Vazquez, et al. 2008 Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients Heart Rhythm 5 1095 1102 10.1016/j.hrthm.2008.04.017 18675217
7. S. de C.A. Morillo F.T. Rabelo, et al. 2008 Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis Eur J Heart Fail 10 1007 1014 10.1016/j.ejheart.2008.07.002
8. J.A. Laukkanen S. Kurl R. Salonen, et al. 2004 The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study Eur Heart J 25 1428 1437 10.1016/j.ehj.2004.06.013 15321701 (Pubitemid 39089077)
9. Feigenbaum H. Echocardiographic evaluation of cardiac chambers. In: Bussy RK, ed. Echocardiography, 5th edn. Philadelphia: Lea & Febiger, 1994:138-140.
10. G.H. Guyatt M.J. Sullivan P.J. Thompson, et al. 1985 The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure CMAJ 132 919 923 1:STN:280:DyaL2M7ltFCksw%3D%3D
11. W.J. Remme 1997 The treatment of heart failure. Task Force of the Working Group on Heart Failure of the ESC Eur Heart J 18 736 753 1:CAS:528: DyaK2sXjtlOntbY%3D
12. Molenberghs G, Kenward MG. Missing data in clinical studies. Chichester: Wiley, 2007.
13. R. Reibis C. Dovifat R. Dissmann, et al. 2006 Implementation of evidence based therapy in patients with systolic heart failure from 1998-2000 Clin Res Cardiol 95 154 156 10.1007/s00392-006-0348-0 1:CAS:528:DC%2BD28XjslWrsrY%3D 16598528 (Pubitemid 43333789)
14. P. Corell F. Gustafsson M. Schou, et al. 2007 Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction Eur J Heart Fail 9 258 265 10.1016/j.ejheart.2006.08.004 17027330 (Pubitemid 46330140)
15. S.J. Pocock D. Wang M.A. Pfeffer, et al. 2006 Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 27 65 75 10.1093/eurheartj/ehi555 16219658 (Pubitemid 41785934)
16. L.G. Olsson K. Swedberg A. Ducharme, et al. 2006 Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program J Am Coll Cardiol 47 1997 2004 10.1016/j.jacc.2006.01.060 16697316
17. Y. Miyasaka M.E. Barnes K.R. Bailey, et al. 2007 Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study J Am Coll Cardiol 49 986 992 10.1016/j.jacc.2006.10.062 17336723
18. M. Amigoni A. Meris J.J. Thune, et al. 2007 Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function Eur Heart J 28 326 333 10.1093/eurheartj/ehl464 17251259
19. G.S. Hillis J.E. Møller P.A. Pellikka, et al. 2005 Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction Am Heart J 2 150 1268 1275 10.1016/j.ahj.2005.01.020 (Pubitemid 41773533)
20. C.A. Pastorius T.D. Henry K.M. Harris 2007 Long-term outcomes of patients with mitral regurgitation undergoing percutaneous coronary intervention Am J Cardiol 100 1218 1223 10.1016/j.amjcard.2007.05.050 17920360 (Pubitemid 47498279)
21. G. de N. Lamblin F. Mouquet, et al. 2008 No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy Arch Cardiovasc Dis 101 242 248 10.1016/S1875-2136(08)73699-4 (Pubitemid 351913869)
22. F. De C. Opasich 2003 Comparison of the outcome in men and women with chronic heart failure Ital Heart J 4 511 513
23. S.D. Solomon N. Anavekar H. Skali, et al. 2005 Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients Circulation 112 3738 3744 10.1161/CIRCULATIONAHA.105.561423 16330684 (Pubitemid 43739514)
24. V. Bittner D.H. Weiner S. Yusuf, et al. 1993 Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators JAMA 270 1702 1707 10.1001/jama.270.14.1702 1:STN:280:DyaK2c%2FhslShsg%3D%3D 8411500 (Pubitemid 23295315)
25. V. Bittner 1999 Determining prognosis in congestive heart failure: role of the 6-minute walk test Am Heart J 138 593 596 10.1016/S0002-8703(99)70166-3 1:STN:280:DyaK1MvjtFCktQ%3D%3D 10502197 (Pubitemid 29471026)
26. A. Passantino R. Lagioia F. Mastropasqua, et al. 2006 Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice J Am Coll Cardiol 48 99 105 10.1016/j.jacc.2006.02.061 16814655 (Pubitemid 43929226)
27. M.R. Shah V. Hasselblad M. Gheorghiade, et al. 2001 Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy Am J Cardiol 88 987 993 10.1016/S0002-9149(01)01975-0 1:STN:280:DC%2BD3MnltVyhuw%3D%3D 11703994 (Pubitemid 33042609)
28. G. Roul P. Germain P. Bareiss 1998 Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J 136 449 445 10.1016/S0002-8703(98)70219-4 1:STN:280:DyaK1cvgsFGnsQ%3D%3D 9736136 (Pubitemid 28413542)
29. 2 slope in patients with heart failure: a prognostic comparison Am Heart J 147 354 360 10.1016/j.ahj.2003.07.014 14760336 (Pubitemid 38176838)
30. R. Arena J. Myers M. Guazzi 2008 The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review Heart Fail Rev 13 245 269 10.1007/s10741-007-9067-5 17987381
31. M. Guazzi J. Myers J. Abella, et al. 2008 The added prognostic value of ventilatory efficiency to the Weber classification system in patients with heart failure Int J Cardiol 129 86 92 10.1016/j.ijcard.2007.05.028 17707926
32. M. Guazzi J. Myers R. Arena 2005 Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure J Am Coll Cardiol 46 1883 1890 10.1016/j.jacc.2005.07.051 16286176 (Pubitemid 41579812)
33. R. Sharma S.D. Anker 2001 The 6-minute walk test and prognosis in chronic heart failure - the available evidence Eur Heart J 22 445 448 10.1053/euhj.2000.2451 1:STN:280:DC%2BD3M3lvFelsw%3D%3D 11237537 (Pubitemid 32619615)
34. L.P. Cahalin M.A. Mathier M.J. Semigran, et al. 1996 The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure Chest 110 325 332 10.1378/chest.110.2.325 1:STN:280:DyaK28zisF2ruw%3D%3D 8697828
35. C. Zugck C. Kruger S. Durr, et al. 2000 Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 21 540 549 10.1053/euhj.1999.1861 1:STN:280:DC%2BD3c3jsFSkuw%3D%3D 10775009 (Pubitemid 30148319)
36. P.L. Enright M.A. McBurnie V. Bittner, et al. 2003 The 6-min walk test: a quick measure of functional status in elderly adults Chest 123 387 398 10.1378/chest.123.2.387 12576356 (Pubitemid 36269420)
37. P. Faggiano A. D'Aloia A. Gualeni, et al. 2004 The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature Eur J Heart Fail 6 687 691 10.1016/j.ejheart.2003.11. 024 15542403 (Pubitemid 39470221)
38. E. Hsich E.Z. Gorodeski R.C. Starling, et al. 2009 Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction Circulation 119 3189 3197 10.1161/CIRCULATIONAHA.109.848382 19528334
39. L. Ingle R.J. Shelton A.S. Rigby, et al. 2005 The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure Eur Heart J 26 1742 1751 10.1093/eurheartj/ehi259 15831556 (Pubitemid 41219847)
40. C. Demers R.S. McKelvie A. Negassa, et al. 2001 RESOLVD Pilot Study Investigators. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure Am Heart J 142 698 703 10.1067/mhj.2001. 118468 1:STN:280:DC%2BD3MrjtlynsQ%3D%3D 11579362 (Pubitemid 32900498)
41. L. Frankenstein A. Remppis J. Graham, et al. 2008 Gender and age related predictive value of walk test in heart failure: do anthropometrics matter in clinical practice? Int J Cardiol 127 331 336 10.1016/j.ijcard.2007.04.087 1:STN:280:DC%2BD1cvhsVKjsg%3D%3D 17689763 (Pubitemid 351894929)
42. J. Myers M. Prakash V. Froelicher, et al. 2002 Exercise capacity and mortality among men referred for exercise testing N Engl J Med 346 793 801 10.1056/NEJMoa011858 11893790 (Pubitemid 34987553)
43. G.S. Bleumink A.M. Knetsch M.C. Sturkenboom, et al. 2004 Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study Eur Heart J 25 1614 1619 10.1016/j.ehj.2004.06.038 15351160 (Pubitemid 39209281)
44. R. Reibis K. Wegscheider V. Basinkevic, et al. 2007 Steadiness of left ventricular ejection fraction after revascularization in patients post myocardial infarction: impact on primary prevention with implantable cardioverter/defibrillator (ICD) J Am Coll Cardiol 49 16A